Mark R. Howard

1.8k total citations
39 papers, 1.3k citations indexed

About

Mark R. Howard is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mark R. Howard has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mark R. Howard's work include Viral-associated cancers and disorders (10 papers), Axon Guidance and Neuronal Signaling (4 papers) and Neuropeptides and Animal Physiology (4 papers). Mark R. Howard is often cited by papers focused on Viral-associated cancers and disorders (10 papers), Axon Guidance and Neuronal Signaling (4 papers) and Neuropeptides and Animal Physiology (4 papers). Mark R. Howard collaborates with scholars based in United Kingdom, United States and Greece. Mark R. Howard's co-authors include Richard S. Tedder, Denise Whitby, Chris Boshoff, Thomas F. Schulz, Robin A. Weiss, Guy R. Simpson, Annemiek de Ruiter, Patrick S. Moore, Angelos Hatzakis and Pamela Cook and has published in prestigious journals such as The Lancet, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Mark R. Howard

37 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Howard United Kingdom 17 716 546 376 277 208 39 1.3k
Jennifer E. Wu United States 17 305 0.4× 196 0.4× 145 0.4× 258 0.9× 183 0.9× 19 1.7k
Paola Gasperini United States 19 393 0.5× 141 0.3× 80 0.2× 370 1.3× 106 0.5× 26 970
Esther Azizi Israel 22 475 0.7× 177 0.3× 90 0.2× 189 0.7× 160 0.8× 50 1.1k
Anneli Peters Germany 12 376 0.5× 120 0.2× 76 0.2× 321 1.2× 125 0.6× 23 2.0k
John S. Tzartos Greece 15 311 0.4× 126 0.2× 129 0.3× 323 1.2× 110 0.5× 69 2.0k
Hans‐Hartmut Peter Germany 25 181 0.3× 196 0.4× 132 0.4× 359 1.3× 70 0.3× 58 2.3k
Alina C. Iuga United States 20 498 0.7× 227 0.4× 185 0.5× 468 1.7× 57 0.3× 39 1.5k
G. Miller United States 9 602 0.8× 314 0.6× 199 0.5× 232 0.8× 148 0.7× 9 948
James M. Gardner United States 17 236 0.3× 155 0.3× 155 0.4× 314 1.1× 132 0.6× 45 1.9k
Marianne Strazza United States 18 387 0.5× 104 0.2× 67 0.2× 397 1.4× 127 0.6× 39 1.3k

Countries citing papers authored by Mark R. Howard

Since Specialization
Citations

This map shows the geographic impact of Mark R. Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Howard more than expected).

Fields of papers citing papers by Mark R. Howard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Howard. The network helps show where Mark R. Howard may publish in the future.

Co-authorship network of co-authors of Mark R. Howard

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Howard. A scholar is included among the top collaborators of Mark R. Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Howard. Mark R. Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Srirajaskanthan, Rajaventhan, et al.. (2023). Optimising Outcomes and Surveillance Strategies of Rectal Neuroendocrine Neoplasms. Cancers. 15(10). 2766–2766. 7 indexed citations
2.
Mirza, Asfand Baig, Melika Akhbari, Christopher Murphy, et al.. (2022). Spontaneous rupture of malignant papillary craniopharyngioma with CSF seeding and metastatic deposits: A case report and literature review. SHILAP Revista de lepidopterología. 2. 100921–100921.
3.
Jacob, Noam, et al.. (2012). Mesenteric paraganglioma’s: an important differential diagnosis in intra-abdominal tumours. BMJ Case Reports. 2012. bcr0220125726–bcr0220125726. 4 indexed citations
4.
5.
6.
Arora, Daleep K., et al.. (2007). Evidence of Postnatal Neurogenesis in Dorsal Root Ganglion: Role of Nitric Oxide and Neuronal Restrictive Silencer Transcription Factor. Journal of Molecular Neuroscience. 32(2). 97–107. 21 indexed citations
7.
Thippeswamy, Thimmasettappa, K. Haddley, Mark R. Howard, et al.. (2006). NO‐cGMP mediated galanin expression in NGF‐deprived or axotomized sensory neurons. Journal of Neurochemistry. 100(3). 790–801. 19 indexed citations
8.
Chandler, Kate, K. Haddley, Mark R. Howard, et al.. (2006). Regulation and role of REST and REST4 variants in modulation of gene expression in in vivo and in vitro in epilepsy models. Neurobiology of Disease. 24(1). 41–52. 74 indexed citations
9.
Gerrard, Lesley, Mark R. Howard, Trevor Paterson, et al.. (2005). A proximal E-box modulates NGF effects on rat PPT-A promoter activity in cultured dorsal root ganglia neurones. Neuropeptides. 39(5). 475–483. 8 indexed citations
10.
McNamee, Christine J., et al.. (2002). Promotion of neuronal cell adhesion by members of the IgLON family occurs in the absence of either support or modification of neurite outgrowth. Journal of Neurochemistry. 80(6). 941–948. 30 indexed citations
11.
McNamee, Christine J., et al.. (2001). Identification and Characterization of CEPU-Se—A Secreted Isoform of the IgLON Family Protein, CEPU-1. Molecular and Cellular Neuroscience. 17(4). 746–760. 21 indexed citations
12.
Howard, Mark R. & Robert A. Smith. (1999). Early diagnosis of septicaemia in preterm infants from examination of peripheral blood films. Clinical & Laboratory Haematology. 21(5). 365–368. 4 indexed citations
13.
Brink, Nicola S., et al.. (1998). Detection of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus DNA in CSF from persons infected with HIV who had neurological disease. Journal of Neurology Neurosurgery & Psychiatry. 65(2). 191–195. 36 indexed citations
14.
Fife, Kathryn, et al.. (1998). Activity of thalidomide in AIDS-related Kaposi's sarcoma and correlation with HHV8 titre. International Journal of STD & AIDS. 9(12). 751–755. 94 indexed citations
15.
Howard, Mark R. & Gulam Bahadur. (1997). Kaposi's sarcoma-associated herpes virus--a new concern for human reproduction?. Human Reproduction. 12(11). 2567–2571. 3 indexed citations
16.
Howard, Mark R., Denise Whitby, Gulam Bahadur, et al.. (1997). Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS. 11(2). F15–F19. 89 indexed citations
17.
Howard, Mark R., et al.. (1996). Regression of AIDS-Related Kaposi's Sarcoma During Therapy with Thalidomide. Clinical Infectious Diseases. 23(3). 501–503. 58 indexed citations
18.
Simpson, Guy R., Thomas F. Schulz, Denise Whitby, et al.. (1996). Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. The Lancet. 348(9035). 1133–1138. 493 indexed citations
19.
Howard, Mark R., B. A. McVerry, & E.H. Cooper. (1988). A longitudinal study of serum beta 2-microglobulin levels in haemophilia. Clinical & Laboratory Haematology. 10(4). 427–434. 3 indexed citations
20.
Howard, Mark R. & B. A. McVerry. (1987). T-CELL LYMPHOMA IN A HAEMOPHILIAC POSITIVE FOR ANTIBODY TO HIV. British Journal of Haematology. 67(1). 115–115. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer E. Wu Breakdown of academic impact, for papers by Paola Gasperini Breakdown of academic impact, for papers by Esther Azizi Breakdown of academic impact, for papers by Anneli Peters Breakdown of academic impact, for papers by John S. Tzartos Breakdown of academic impact, for papers by Hans‐Hartmut Peter Breakdown of academic impact, for papers by Alina C. Iuga Breakdown of academic impact, for papers by G. Miller Breakdown of academic impact, for papers by James M. Gardner Breakdown of academic impact, for papers by Marianne Strazza
Rankless by CCL
2026